• English
  • Italiano
HEAL ITALIA
  • Fondazione
    • Organi direttivi e consultivi
    • Unit for European Strategic Intelligence
    • Partner
  • Progetto HEAL Italia
    • Heal Italia Roadshow
    • Campagna Providentia
    • HEAL Italia Forum 2026
    • Network Tematici
      • Nosologia Olistica e Omica
      • Salute Intelligente e Dati
      • Modelli Predittivi
      • Diagnostica di Precisione
      • Terapie di Nuova Generazione
      • Dispositivi medici e Tecnologie
      • Prevenzione personalizzata
      • Sperimentazione Clinica
  • Pubblicazioni
  • Servizi
    • HEAL Italia Academy
    • Internazionalizzazione
      • Heal Italia all’estero
    • Trasferimento Tecnologico
  • Avvisi
    • Assegnatari Progetti BAC
    • Bandi a Cascata
    • Bandi HUB
  • Core Facilities
    • Network Biobanche Heal Italia con BBMRI
  • News
    • Rassegna stampa

Cerca nel sito

Pubblicazioni

L’Archivio delle oltre 600 pubblicazioni realizzate durante il programma HEAL Italia, organizzate secondo cluster di patologia, periodo e network tematici (Spoke) del progetto.

Interplay Between Glutamine Metabolism and Other Cellular Pathways: A Promising Hub in the Treatment of HNSCC
2025 Spoke 4 Oncologia e terapie innovative Studi preclinici sui i meccanismi fondamentali delle malattie

Dell’Endice TS, Posa F, Storlino G, Sanesi L, Lo Russo L, Mori G.

Immunonutrition supplementation for resectable gastric cancer during standard neoadjuvant chemotherapy of FLOT. A proof-of-concept protocol: I-SUPPLY
2024 Spoke 4 Oncologia e terapie innovative

Pusceddu V, Donisi C, Pretta A, Loi F, Badas R, Ziranu P, Puzzoni M, Lai E, Mariani S, Palmas E, Pozzari M, Cimbro E, D’Agata AP, Pinto S, Coghe F, Bergamini S, Fanni D, Faa G, Yoshino T, Scartozzi M .

Impact of the Human Leukocyte Antigen Complex on Idiopathic Pulmonary Fibrosis Development and Progression in the Sardinian Population
2025 Spoke 1 Apparato respiratorio e patologie sistemiche correlate

Serra M, Mocci S, Deidda S, Melis M, Chessa L, Lai S, Giuressi E, Mereu C, Sanna C, Lorrai M, Murgia M, Cannas F, Mascia A, Perra A, Littera R, Giglio S

Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging
2024 Spoke 4 Oncologia e terapie innovative

Corrias G, Lai E, Ziranu P, Mariani S, Donisi C, Liscia N, Saba G, Pretta A, Persano M, Fanni D, Spanu D, Balconi F, Loi F, Deidda S, Restivo A, Pusceddu V, Puzzoni M, Solinas C, Massa E, Madeddu C, Gerosa C, Zorcolo L, Faa G, Saba L, Scartozzi M.

Early-onset colorectal cancer patients exhibit a distinct molecular fingerprint: insights from a large-scale NGS study of 1209 patients
2025 Spoke 4 Diagnostica avanzata Oncologia e terapie innovative

Pretta A, Nasca V, Marmorino F, Intini R, Ziranu P, Randon G, Carullo M, Cerma K, Donisi C, Damonte C, Taravella A, Gaiani C, Pretta G, Pusceddu V, Montroni I, Ciracì P, De Rosa A, Bergamo F, Lonardi S, Cremolini C, Pietrantonio F, Scartozzi M.

Untargeted lipidomics by LC-QTOF-MS for biomarker selection and discrimination of plant- and animal-derived rennet in cooked-curd ovine cheese at different ripening stages
2026 Spoke 1 Studi preclinici sui i meccanismi fondamentali delle malattie

Sibono L, Grosso M, Errico M, Tronci S, Lai G, Pes M, Addis M, Caboni P, Manis C.

An improved dataset of force fields, electronic and physicochemical descriptors of metabolic substrates
2024 Spoke 2 Diagnostica avanzata

Macorano A, Mazzolari A, Malloci G, Pedretti A, Vistoli G, Gervasoni S.

Spatial lipidomics profiling of Bottarga (Mugil cephalus) by LC-HRMS using a QTOF platform: A comprehensive characterization of complex lipid
2026 Spoke 1 Studi preclinici sui i meccanismi fondamentali delle malattie

Manis C, Casula M, Angioni A, Scano P, Rosa A, Caboni P.

Computational studies of target-specific radiopharmaceuticals for theranostics
2026 Spoke 2 Diagnostica avanzata

Gervasoni S, Guccione C, Malloci G.

Exploring key features of selectivity in somatostatin receptors through molecular dynamics simulations
2024 Spoke 2 Diagnostica avanzata

Guccione C, Gervasoni S, Öztürk I, Bosin A, Ruggerone P, Malloci G.

Decoding the role of mesothelin in tumor dynamics and targeted treatment innovations
2025 Spoke 3 Oncologia e terapie innovative

Silvestri R, Colucci E, Piccardi M, Landi S, Gemignani F 

Molecular simulations of SSTR2 dynamics and interaction with ligands
2023 Spoke 2 Studi preclinici sui i meccanismi fondamentali delle malattie

Gervasoni S, Guccione C, Fanti V, Bosin A, Cappellini G, Golosio B, Ruggerone P, Malloci G.

Development of a Mesothelin-Binding Engineered Scaffold Protein as a Theranostic for Pleural Mesothelioma
2025 Spoke 3 Oncologia e terapie innovative

Silvestri R, Piccardi M, Laurenza A, Rea F, Sirois AR, Lari M, Bartoli F, Signore G, Tedeschi L, Ferraro E, Erba PA, Giovannoni R, Landi S, Gemignani F, Moore SJ.

Genomic profiling in hepatocellular carcinoma: a real-world retrospective analysis
2025 Spoke 8 Oncologia e terapie innovative

Salani F, Ponziani FR, Piscaglia F, Malapelle U, Daniele B, Porta C, Pradelli L, De Fiore E, Masi G, Rimassa L, Casadei Gardini A

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours
2024 Spoke 8 Malattie infettive e Immunologia Oncologia e terapie innovative

Celsa C, Cabibbo G, Fulgenzi CAM, Scheiner B, D’Alessio A, Manfredi GF, Nishida N, Ang C, Marron TU, Saeed A, Wietharn B, Pinter M, Cheon J, Huang YH, Lee PC, Phen S, Gampa A, Pillai A, Vivaldi C, Salani F, …..

A Misleading Case of NTRK-Rearranged Papillary Thyroid Carcinoma
2024 Spoke 8 Oncologia e terapie innovative

Francesco Demetrio Lofaro, Dilia Giuggioli, Susanna Bonacorsi, Martina Orlandi, Amelia Spinella, Marco De Pinto, Ottavio Secchi, Clodoveo Ferri, Federica Boraldi 

Synthesis and Application of a Glucoconjugated Organometallic Rhenium Complex as an IR Imaging Probe for Glycolytic Cancer Cells
2025 Spoke 3 Oncologia e terapie innovative

Bononi G, Paltrinieri E, Fortunato S, Cicio G, Di Giovanni N, Lencioni G, Funel N, Giovannetti E, Granchi C, Di Bussolo V,
Minutolo F.

BMP-4 and fetuin A in systemic sclerosis patients with or without calcinosis
2024 Spoke 8 Studi preclinici sui i meccanismi fondamentali delle malattie

Francesco Demetrio Lofaro, Dilia Giuggioli, Susanna Bonacorsi, Martina Orlandi, Amelia Spinella, Marco De Pinto, Ottavio Secchi, Clodoveo Ferri, Federica Boraldi 

The importance of body image and aesthetic medicine in systemic sclerosis
2024 Spoke 8 Diagnostica avanzata

Orlandi M, Spinella A, De Pinto M, Sandri G, De Santis G,
Giuggioli D.

Metabolic Disorders in Liver Transplant Recipients: The State of the Art
2024 Spoke 1 Malattie metaboliche e infiammazione sistemica

Filippo Gabrielli, Lucia Golfieri, Fabio Nascimbeni, Pietro Andreone, Stefano Gitto 

Eosinophil-airway epithelial cell crosstalk reveals the eosinophil-mediated DUOX1 upregulation in a murine allergic inflammation setting
2025 Spoke 1 Malattie metaboliche e infiammazione sistemica

Carla Raggi , Francesca Spadaro , Fabrizio Mattei , Adriana Rosa Gambardella , Francesco Noto , Sara Andreone , 
Michele Signore , Giovanna Schiavoni , Isabella Parolini , Claudia Afferni 

Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort
2025 Spoke 8 Diagnostica avanzata

Carmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale, Elisa Diral, Alessandro Tomelleri, Elisa Galossi, Giulia Falconi, Alessandro Bruno, Francesca Crisafulli, Micol Frassi, Chiara Cattaneo, Diego Bertoli, Massimo Bernardi, Annalisa Condorelli, Erika Morsia, Antonella Poloni, Elena Crisà, Daniela Caravelli, Paola Triggianese, Luisa Brussino, Giorgia Battipaglia, Sara Bindoli, Paolo Sfriso, Federico Caroni, Matteo Dragani, Flavia Mallegni, Federica Pilo, Davide Firinu, Antonio Curti, Cristina Papayannidis, Attilio Olivieri, Sharham Kordasti, Francesco Albano, Fabrizio Pane, Pellegrino Musto, Monica Bocchia, Elisabetta Lugli, Massimo Breccia, Marco Frigeni, Lorenzo Dagna, Raffaella Greco, Franco Franceschini, Corrado Campochiaro, Luca Cantarini, Maria Teresa Voso

Maternal Dietary Pattern in Pregnancy and Behavioral Outcomes at 4 Years of Age in the Piccolipiù Cohort: Potential Sex-Related Differences
2025 Spoke 7 Medicina di genere

Letizia Leccese , Lorenza Nisticò, Martina Culasso, Costanza Pizzi , Vieri Lastrucci , Luigi Gagliardi , 
Sonia Brescianini 

Breastfeeding and Sociodemographic Determinants: Evidence from the “MAMI-MED” Cohort
2025 Spoke 7 Diagnostica avanzata

Giuliana Favara, Andrea Maugeri, Martina Barchitta, Roberta Magnano San Lio, Maria Clara La Rosa, Claudia La Mastra, Erminia Di Liberto, Fabiola Galvani, Elisa Pappalardo, Carla Ettore, Giuseppe Ettore, Antonella Agodi 

Amine-Functionalized Gellan Gum-Based Hydrogel Loaded with Adipose Stem Cell-Derived Small Extracellular Vesicles: An In Vitro Proof of Concept for Enhancing Diabetic Foot Ulcer Healing
2025 Spoke 6 Tecnologie avanzate e modelli sperimentali

Laura Tomasello , Mattia Biondo , Giuseppina Biscari , Luigi Di Rosa , Fabio Salvatore Palumbo , Calogero Fiorica , Giovanna Pitarresi , Sonya Vasto, Giuseppe Pizzolanti , Giorgio Arnaldi

H105A peptide eye drops promote photoreceptor survival in murine and human models of retinal degeneration
2025 Spoke 6 Studi preclinici sui i meccanismi fondamentali delle malattie

Bernardo-Colón A, Bighinati A, Parween S, Debnath S, Piano I, Adani E, Corsi F, Gargini C, Vergara N, Marigo V,
Patricia Becerra S. 

FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022
2023 Spoke 5 Tecnologie avanzate e modelli sperimentali

Rizzo C, Amata S, Pibiri I, Pace A, Buscemi S, Palumbo Piccionello A

Activation and inhibition of sirtuins: From bench to bedside
2025 Spoke 5 Tecnologie avanzate e modelli sperimentali

Fiorentino F, Fabbrizi E, Mai A, Rotili D

State of the art of carbonic anhydrase activators
2023 Spoke 5 Tecnologie avanzate e modelli sperimentali

Fiorentino F, Carta F, Rotili D, Mai A, Supuran CT.

Challenges in the diagnosis and management of AIH-PBC syndrome
2024 Spoke 4 Malattie metaboliche e infiammazione sistemica

Gerussi, A., Invernizzi, P. & Carbone, M. (2024). 

Therapeutic Potential of Solenopsis invicta Venom: A Scoping Review of Its Bioactive Molecules, Biological Aspects, and Health Applications
2024 Spoke 4 Diagnostica avanzata Tecnologie avanzate e modelli sperimentali

Mario Dioguardi, Stefania Cantore, Diego Sovereto, Lorenzo Sanesi, Angelo Martella, Lynn Almasri, Gennaro Musella, Lorenzo Lo Muzio, Andrea Ballini 

Gene expression in organoids: an expanding horizon
2023 Spoke 3 Tecnologie avanzate e modelli sperimentali

Artem Smirnov , Gerry Melino , Eleonora Candi 

Transcriptomic Profile of Human Osteoblast-like Cells Grown on Trabecular Titanium
2025 Spoke 3 Tecnologie avanzate e modelli sperimentali

Giovanna Castoldi  , Mario Mauri  , Deborah D’Aliberti  , Silvia Spinelli  , Leonardo Testa  , Federico Gaverina  , Alessandro Rubinacci  , Isabella Villa  , Giuseppe Bellelli , Gianpaolo Zerbini  , Rocco Piazza  , Giovanni Zatti 

Deletion of p63 exon 13 in mice reveals C-terminal isoform-specific functions in epithelial development
2025 Spoke 1 Spoke 3 Studi preclinici sui i meccanismi fondamentali delle malattie

Nannini M, Astolfi A, Maloberti T, Nigro MC, Gozzellino L, Costa A, Pirini MG, De Leo A, Grillini M, Altimari A, Del Gaudio M, Vincenzi B, Fumagalli E, Brunello A, Grignani G, Aliberti S, Ricci AD, Gelsomino F, Setola E, Tallini G, de Biase D, Pantaleo MA. 

Performance and clinical utility of two targeted multigene panels for GIST molecular characterization
2025 Spoke 8 Studi preclinici sui i meccanismi fondamentali delle malattie

Nannini M, Astolfi A, Maloberti T, Nigro MC, Gozzellino L, Costa A, Pirini MG, De Leo A, Grillini M, Altimari A, Del Gaudio M, Vincenzi B, Fumagalli E, Brunello A, Grignani G, Aliberti S, Ricci AD, Gelsomino F, Setola E, Tallini G, de Biase D, Pantaleo MA. 

EMG-Informed Neuromusculoskeletal Simulations Increase the Accuracy of the Estimation of Knee Joint Contact Forces During Sub-optimal Level Walking
2025 Spoke 2 Diagnostica avanzata

Domitille Princelle1 · Marco Viceconti 1,2 · Giorgio Davico

Therapeutic potential of lorlatinib in ALK-mutated metastatic paraganglioma: Insights from clinical case report and literature review
2025 Spoke 8 Oncologia e terapie innovative

Nigro MC, Corradi G, Nannini M, Di Dalmazi G, Tucci L, Tolento G, Nanni C, Golemi A, De Leo A, De Biase D, Mosconi C, Balacchi C, Vicennati V, Pantaleo MA. 

Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials
2025 Spoke 8 Oncologia e terapie innovative

Germani MM, Borelli B, Hashimoto T, Nakamura Y, Oldani S, Battaglin F, Bergamo F, Salvatore L, Stahler A, Antoniotti C, Shitara K, Venook A, Oki E, Muro K, Ugolini C, Soeda J, Lonardi S, Pietrantonio F, Lenz HJ, Modest DP, Yoshino T, Cremolini C.

Risk of disease progression in first-line metastatic colorectal cancer therapy to guide disease reassessments-analysis of 11 trials by AIO and GONO
2025 Spoke 8 Oncologia e terapie innovative

Germani MM, Heinemann V, Rossini D, Fischer von Weikersthal L, Pietrantonio F, Heinrich K, Stahler A, Lonardi S, Kaiser F, Decker T, Salvatore L, Weiss L, Morano F, Fuchs M, Bergamo F, Antoniotti C, Masi G, Stintzing S, Frumento P, Cremolini C, Modest DP.

Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study
2025 Spoke 8 Oncologia e terapie innovative

Kopp RM, Massari F, Grande E, Schieber TJ, Ürün Y, Kopecký J, Molina-Cerrillo J, Basso U, Kucharz J, Büttner T, Pichler R, Fiala O, Myint ZW, Galli L, Buchler T, Rizzo M, Bolek H, Bourlon MT, Conteduca V, Pinto A, Rizzo A, Rosellini M, Roviello G, Zgura A, Mollica V, Partl A, Yildirim A, Akova U, Buti S, Monteiro FSM, Soares A, Porta C, Bilen MA, Li H, Santoni M. 

Neoadjuvant immunotherapy for dMMR/MSI-H locally advanced rectal cancer patients: demystifying the 100% clinical complete response paradigm
2025 Spoke 8 Oncologia e terapie innovative

Marmorino F, Morano F, Canciello MA, Rossi P, Gandini A, Laurent-Puig P, Ugolini C, Martinelli E, Cremolini
C. 

Re-treatment with panitumumab followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with RAS and BRAF wild-type circulating tumor DNA: the PARERE study by GONO
2026 Spoke 8 Oncologia e terapie innovative

Ciracì P, Germani MM, Pietrantonio F, Manca P, Lonardi S, Busico A, Bergamo F, Burgio V, Mannavola F, Di Donato S, Fenocchio E, Palermo F, Capone I, De Grandis MC, Pella N, Scartozzi M, Antonuzzo L, Passardi A, Claravezza M, Salvatore L, Tamberi S, Randon G, Conca E, Conca V, Antoniotti C, Moretto R, Masi G, Boni L, Rossini D, Cremolini C; GONO Foundation Investigators.

Pattern alimentari in gravidanza: associazioni con fattori sociodemografici e outcome materno-infantili
2025 Spoke 7 Diagnostica avanzata

Letizia Leccese, Lorenza Nisticò, Giorgia Bazzurri, Martina Culasso, Vieri Lastrucci, Daniela Porta, Lorenzo Richiardi, Luca Ronfani, Franca Rusconi, Sonia Brescianini

Trafficking of luteinizing hormone receptor directs the differential signal activation between luteinizing hormone and chorionic gonadotropin
2025 Spoke 7 Studi preclinici sui i meccanismi fondamentali delle malattie

Clara Lazzaretti , Elia Paradiso  , Samantha Sperduti  , Rachel R Richardson  , Carmela Perri  , Riccardo Bellei  , Sara D’Alessandro  , Lara Baschieri  , Claudia Fusco  , Frederic Jean-Alphonse  , Eric Reiter  , Monica Lispi  , Manuela Simoni  , Aylin C Hanyaloglu  , Livio Casarini 

Seeking Novel Personalized and Sex-Specific Strategies for the Prevention and Treatment of Heart Failure Based on the Assessment of β1-Adrenergic Receptor Desensitization: The Contribution to the HEAL ITALIA Project
2026 Spoke 7 Medicina di genere

Vona R, Cittadini C, Mattia G, Puglisi R, Ascione B, Gambardella L, Maccari S, Marano G, Matarrese P.

Prognostic Role of Worst Pattern of Invasion in Oral Squamous Cell Carcinoma
2026 Spoke 7 Diagnostica avanzata Oncologia e terapie innovative

Lucrezia Togni, Marco Mascitti, Paolo Maria Antonio Staffinati, Giuseppe Consorti, Gaetano Isola, Lucio Lo Russo, Andrea Santarelli   

Zinc-L-carnosine mouthwash in oral mucositis patients: a single-blind, randomized, controlled trial
2026 Spoke 7 Tecnologie avanzate e modelli sperimentali

Lucrezia Togni, Scilla Sparabombe, Marco Mascitti, Alberta Barlattani, Gaetano Isola, Lucio Lo Russo, Andrea Santarelli

Red blood cell-derived extracellular vesicles as biomaterials: the opportunity of freezing-induced accelerated aging
2026 Spoke 5 Tecnologie avanzate e modelli sperimentali

Lucia Paolini , Miriam Romano , Valentina Mangolini  , Selene Tassoni  , Shuhan Jiang  , Elena Laura Mazzoldi  , Angelo Musicò  , Andrea Zendrini, Anna Kashkanova , Vahid Sandoghdar  , Anna C Berardi , Silvia Clara Giliani  , Paolo Bergese  , Annalisa Radeghieri 

Combined in vitro differentiation and cell sorting-based isolation of highly pure mouse bone marrow-derived basophils
2025 Spoke 7

Adriana Rosa Gambardella, Valentina Tirelli, Sara Andreone, Jacopo Mancini, Fabrizio Mattei, Giovanna Schiavoni

Assessment of in vitro interactions between eosinophils and cancer cells by imaging-enhanced flow cytometry and time lapse microscopy
2025 Spoke 7 Oncologia e terapie innovative Tecnologie avanzate e modelli sperimentali

Caterina Antonucci, Adriana Rosa Gambardella, Valentina Tirelli, Fabrizio Mattei, Giovanna Schiavoni 

  1. «
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. 8
  10. 9
  11. 10
  12. »

Fondazione HEAL ITALIA
Sede Operativa: Via Isidoro La Lumia 19C, Palermo PA
Complesso Monumentale dello Steri,
Piazza Marina, 61, Palermo PA
info@healitalia.eu

Dona il tuo 5×1000 alla ricerca
Codice Fiscale Heal Italia: 97370050821

  • Home
  • Rassegna Stampa
  • Fondazione trasparente
  • Termini e condizioni di utilizzo
  • Procedura per i diritti degli interessati
  • Privacy policy
  • Cookie policy
  • Informativa email
  • Contatti
  • Partner
  • News
  • Chi siamo

Questo sito è stato sviluppato dalla Fondazione HEAL ITALIA nell’ambito del progetto finanziato dall’Unione europea – (NextGenerationEU) – PNRR Missione 4, Componente 2, Investimento 1.3.